Bhutan vs Norway: Proportion of isolates with decreased susceptibility or resistance
Bhutan
0
in 2018
Norway
0
in 2018
Bhutan rank
25th
Norway rank
25th
Proportion of isolates with decreased susceptibility or resistance over time
- Bhutan
- Norway
How they compare
Bhutan currently reports 0 against 0 in Norway, a difference of 0.
The two have swapped places 4 times across 8 shared years of data; in 2009 it was Norway ahead.
Bhutan ranks 25th and Norway ranks 25th of 51 countries.
Norway has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bhutan | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 0.9091 | 0.9091 | Norway |
| 2010s | 1.74 | 2.41 | 0.6759 | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Bhutan or Norway?
- Bhutan, at 0 against 0 in Norway as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Bhutan and Norway?
- 0, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Norway?
- 8 years are reported by both, from 2009 to 2018.
- How do Bhutan and Norway rank globally for proportion of isolates with decreased susceptibility or resistance?
- Bhutan ranks 25th and Norway ranks 25th of 51 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to extended-spectrum cephalosporins reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.